---
title: "Malattie rare: Egpa, Fede (AstraZeneca), ‘rimborsabilità di benralizumab traguardo importante’"
description: Your browser does not support the video tag.
featured_image: https://laragione.eu/wp-content/uploads/adnkronos-images/2026205_1445_INTERMEDIA_PILLOLA_FEDE_LEANEWS_video-hd-1024x576.jpg
date: 2026-05-20
author: adnkronos
url: https://laragione.eu/adnkronos/video-adnkronos/malattie-rare-egpa-fede-astrazeneca-rimborsabilita-di-benralizumab-traguardo-importante/
categories: [Video]
---

# Malattie rare: Egpa, Fede (AstraZeneca), ‘rimborsabilità di benralizumab traguardo importante’

![Malattie rare: Egpa, Fede (AstraZeneca), ‘rimborsabilità di benralizumab traguardo importante’](https://laragione.eu/wp-content/uploads/adnkronos-images/2026205_1445_INTERMEDIA_PILLOLA_FEDE_LEANEWS_video-hd-1024x576.jpg)

Your browser does not support the video tag.